Ray Co., Ltd. (KOSDAQ:228670)
South Korea
· Delayed Price · Currency is KRW 5,020.00
-330.00 (-6.17%)
Mar 9, 2026, 3:30 PM KST
Ray Co., Ltd. Revenue
Ray Co., Ltd. had revenue of 30.33B KRW in the quarter ending September 30, 2025, with 35.00% growth. This brings the company's revenue in the last twelve months to 97.57B, down -13.31% year-over-year. In the year 2024, Ray Co., Ltd. had annual revenue of 79.84B, down -45.27%.
Revenue (ttm)
97.57B
Revenue Growth
-13.31%
P/S Ratio
0.80
Revenue / Employee
548.12M
Employees
178
Market Cap
78.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79.84B | -66.04B | -45.27% |
| Dec 31, 2023 | 145.88B | 16.88B | 13.09% |
| Dec 31, 2022 | 129.00B | 38.66B | 42.80% |
| Dec 31, 2021 | 90.34B | 35.13B | 63.64% |
| Dec 31, 2020 | 55.20B | -17.90B | -24.49% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sugentech | 9.01B |
| Gencurix | 3.39B |
| P&S Robotics | 8.55B |
| LabGenomics | 89.36B |
| HASS Corp. | 17.18B |
| IVIM Technology | 4.59B |
| Osang Healthcare Co.,Ltd | 119.03B |
| T&R Biofab | 20.67B |